![Henk Viëtor](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Henk Viëtor
Fondateur chez MyLife Technologies BV
Provenance du réseau au premier degré de Henk Viëtor
Entité | Type d'entité | Industrie | |
---|---|---|---|
Skyline Diagnostics BV
![]() Skyline Diagnostics BV Electronic Equipment/InstrumentsElectronic Technology Skyline Diagnostics develops and commercializes diagnostic microarrays for oncology. These tests currently provide the healthcare professional diagnostic information using one comprehensive test and may be useful in the clinical management of patients with cancer. Skyline Diagnostics products are currently available research only tools in the United States. The development pipeline includes diagnostic tests for Acute Myeloid Leukemia, Multiple Myeloma, Acute Lymphatic Leukemia, and Brain tumors.
12
| Extinct | Electronic Equipment/Instruments | 12 |
MyLife Technologies BV
![]() MyLife Technologies BV Medical SpecialtiesHealth Technology MyLife Technologies BV develops ceramic microneedle arrays technology. The firm also offers tailor-made npMNA designs, which vary in needle and array dimensions, number of needles per array, and array cavities. The company was founded by Pieter Jan Vos, Regina Luttge and Henk Vietor in 2008 and is headquartered in Enschede, the Netherlands.
2
| Holding Company | Medical Specialties | 2 |
Oncodrone BV
![]() Oncodrone BV BiotechnologyHealth Technology Oncodrone BV develops novel therapeutics for epithelial derived malignancies including prostate, breast, lung, pancreas and bladder cancer. It focuses on developing novel therapeutics for advanced cancer by targeting: Epithelial-to-Mesenchymal Transition (EMT) and Androgen Receptor (AR) Signaling. The company was founded in 2013 and is headquartered in Nijmegen, the Netherlands.
1
| Private Company | Biotechnology | 1 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Henk Viëtor via son réseau personnel
Société | Secteur | Personnes liées | Poste principal |
---|---|---|---|
CAMPBELL SOUP COMPANY | Food: Specialty/Candy | Director/Board Member | |
Gerber Products Co., Inc.
![]() Gerber Products Co., Inc. Food: Specialty/CandyConsumer Non-Durables Gerber Products Co. manufactures and supplies baby foods and infant care items. The firm also makes baby cereal, juices and toddler food along with baby bath and skincare products, bottles, tethers, breastfeeding accessories, spill-proof cups, infant toys and clothing. The company was founded in 1928 and is headquartered in Fremont, MI. | Food: Specialty/Candy | Chief Executive Officer | |
NESTLÉ S.A. | Food: Major Diversified | Corporate Officer/Principal | |
BMEYE BV
![]() BMEYE BV Electronic Equipment/InstrumentsElectronic Technology BMEYE BV operates as a non-invasive cardiovascular monitoring company. The firm manufactures and distributes non-invasive technology, hemodynamic monitoring equipment and related medical devices. It offers finger arterial pressure and cardiac output technologies. The company was founded in April 2005 and is headquartered in Amsterdam, the Netherlands. | Electronic Equipment/Instruments | Director/Board Member | |
Coöperatief LSP IV UA | Investment Managers | Director/Board Member | |
CRONOS GROUP INC. | Pharmaceuticals: Other | Chief Executive Officer | |
LSP Management Group BV
![]() LSP Management Group BV Investment ManagersFinance LSP Management Group BV (LSP) is an independent European venture capital firm which was founded by Martijn Kleijwegt, Frits van der Have and Tom Schwarz in 1998. Headquartered in Amsterdam, the firm provides financing to early- to mid-stage life science companies. | Investment Managers | Private Equity Investor | |
Wake Forest University | College/University | Undergraduate Degree | |
Dr. Reddy's Research & Development BV
![]() Dr. Reddy's Research & Development BV Pharmaceuticals: MajorHealth Technology Dr. Reddy's Research & Development BV is engaged in the development and manufacture of injectable pharmaceutical products. It provides formulation, development, drug delivery, and clinical material manufacturing services to biotech and pharmaceutical companies worldwide. The company was founded by Joost J. M. Holthuis on July 20, 1995 and is headquartered in Leiden, Netherlands. | Pharmaceuticals: Major | Corporate Officer/Principal | |
University of California, Los Angeles | College/University | Undergraduate Degree | |
Abbott Healthcare Products BV
![]() Abbott Healthcare Products BV Pharmaceuticals: MajorHealth Technology Part of Abbott Laboratories, Abbott Healthcare Products BV is a Dutch company that manufactures and distributes pharmaceuticals. The company is based in Weesp, Netherlands. | Pharmaceuticals: Major | Corporate Officer/Principal | |
The University of Chicago | College/University | Masters Business Admin | |
United States Naval Academy | College/University | Undergraduate Degree | |
Erasmus University Rotterdam | College/University | Doctorate Degree Corporate Officer/Principal | |
University of Leiden | College/University | Undergraduate Degree Doctorate Degree | |
University of Utrecht | College/University | Graduate Degree Undergraduate Degree | |
University of Groningen | College/University | Graduate Degree Undergraduate Degree | |
MyCartis NV
![]() MyCartis NV BiotechnologyHealth Technology MyCartis NV develops technologies for healthcare personalization needs. It offers Evalution, a multiplex analysis platform to develop protein and nucleic-acid based clinical biomarkers. The company provides disruptive solutions in the fields of clinical and translational research for various applications in the detection of proteins and nucleic acids, such as sandwich immunoassays, antibody assays, genotyping assays, and mutation analysis assays to customers and partners. It offers products for various disease areas, including cell signalling, cardiovascular, oncology, and preeclampsia. The company was founded by Koen Kas in August 2004 and is headquartered in Ghent, Belgium. | Biotechnology | Director/Board Member | |
The Royal Netherlands Academy of Arts & Sciences
![]() The Royal Netherlands Academy of Arts & Sciences Miscellaneous Commercial ServicesCommercial Services The Royal Netherlands Academy of Arts & Sciences provides research services in the field of science and art. The private company is based in Amsterdam, Netherlands and has subsidiaries in Netherlands. The CEO of the Dutch company is Wilma de Koning. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
The Blue Buffalo Co. Ltd.
![]() The Blue Buffalo Co. Ltd. Food: Specialty/CandyConsumer Non-Durables The Blue Buffalo Co. Ltd. manufactures and supplies dogs and cats food. Its products include life protection formula, wilderness, and organics. The firm also provides chicken and brown rice, lamb and brown rice, and fish and sweet potato recipes. The company was founded by Bill Bishop and is headquartered in Wilton, CT. | Food: Specialty/Candy | Chief Executive Officer | |
MERUS N.V. | Biotechnology | Director/Board Member | |
Philips Home Healthcare Solutions | Private Equity Investor | ||
ARGENX SE | Pharmaceuticals: Other | Director/Board Member | |
Semaia Pharmaceuticals | Chief Executive Officer | ||
Specs Compound Handling BV
![]() Specs Compound Handling BV Wholesale DistributorsDistribution Services Specs Compound Handling BV provides compound management services. It supplies research compounds to the life science industry. The firm offers services from its two main logistic centers in The Netherlands and Maryland, USA. The company was founded in 1987 and is headquartered in Zoetermeer, the Netherlands. | Wholesale Distributors | Chief Executive Officer | |
SkylineDx BV
![]() SkylineDx BV Medical/Nursing ServicesHealth Services SkylineDx BV develops molecular diagnostic tests for blood cancers. The firm focuses on the development and commercialization of gene signature-based diagnostic tests, which assist healthcare professionals in making personalized treatment decisions for individual patients. Its products include MMprofiler and AMLprofiler. The company was founded by Dharminder S. Chahal and Bob Löwenberg in 2005 and is headquartered in Rotterdam, the Netherlands. | Medical/Nursing Services | Founder Chief Operating Officer | |
BLUE BUFFALO PET PRODUCTS INC | Food: Specialty/Candy | Chief Executive Officer | |
Scheller College of Business | College/University | Masters Business Admin | |
eTheRNA immunotherapies NV
![]() eTheRNA immunotherapies NV BiotechnologyHealth Technology eTheRNA immunotherapies NV develops novel immunotherapies to overcome cancers and infectious diseases. The company was founded by Carlo Heirman, Kris Thielemans and Sonja van Meirvenne in January 21, 2013 and is headquartered in Niel, Belgium. | Biotechnology | Director/Board Member | |
Onward Medical SA
![]() Onward Medical SA BiotechnologyHealth Technology ONWARD Inc develops medical devices. It also provides stimulation system to rehabilitate individuals with spinal cord injury. The company was founded by Jocelyn Bloch, Sjaak Deckers, Grégoire Courtine, and Vincent Delattre in December 2014 and is headquartered in Lausanne, Switzerland. | Biotechnology | Director/Board Member | |
Xylocor Therapeutics, Inc.
![]() Xylocor Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Xylocor Therapeutics, Inc. engages in the biopharmaceutical company that develops gene therapy for people with advanced coronary artery disease. It focuses on developing product for patients with refractory angina with no treatment options and its secondary product for patients with cardiac tissue damage from heart attacks. The company was founded by Ronald Crystal and Todd Rosengart in 2013 and is headquartered in Malvern, PA. | Pharmaceuticals: Major | Director/Board Member | |
Varmx BV
![]() Varmx BV BiotechnologyHealth Technology VarmX BV is a spin-off from Leiden University Medical Center (LUMC) founded in 2016 by Professor Pieter Reitsma, a world-leading expert in hemostasis and thrombosis. VarmX is based in Leiden, NL. The Dutch company's lead compound, VMX-C001, is a modified recombinant blood factor X developed for the treatment of severe spontaneous bleeding and for the prevention of bleeding during urgent surgery in patients taking oral factor Xa inhibitors (FXa DOACs) as anticoagulation therapy. The company is supported by a strong syndicate of investors. Jan K. Öhrström has been the CEO of the company since 2018. | Biotechnology | Director/Board Member | |
Pilot Mountain Ventures LP
![]() Pilot Mountain Ventures LP Investment ManagersFinance Pilot Mountain Ventures (Pilot Mountain) is a venture capital firm founded in 2012 by Steve Perricone. The firm is headquartered in New York. | Investment Managers | Private Equity Investor | |
Aelin Therapeutics NV
![]() Aelin Therapeutics NV Pharmaceuticals: MajorHealth Technology Aelin Therapeutics NV develops drugs for antibiotics and first-in-class therapeutics. The company is based in Leuven, Belgium. The Belgian company was founded in 2017. The CEO is Els Beirnaert. | Pharmaceuticals: Major | Director/Board Member | |
Qurin Diagnostics BV
![]() Qurin Diagnostics BV BiotechnologyHealth Technology Qurin Diagnostics BV develops diagnostic devices to non invasively detect early stage cancer of multiple types. The company was founded by Roderik Kraaijenhagen and is headquartered in Enschede, the Netherlands. | Biotechnology | Chief Operating Officer | |
VITURA HEALTH LIMITED | Pharmaceuticals: Other | Director/Board Member | |
xCures, Inc.
![]() xCures, Inc. Packaged SoftwareTechnology Services xCures, Inc. engages in the development of artificial intelligence (AI) based precision oncology platform. It offers patients and physicians an individualized treatment options and facilitates access via reimbursement, clinical trials, and access support. The company was founded by Jeff Shrager and Jay Marty Tenenbaum in 2018 and is headquartered in Los Altos, CA. | Packaged Software | Private Equity Investor | |
Xilis, Inc.
![]() Xilis, Inc. Medical SpecialtiesHealth Technology Xilis, Inc. engages in the development of droplet-based microfluidics technology devices for precision cancer diagnostics and drug development. It offers Xilis platform. The company was founded by Xiling Shen and David Shu and is headquartered in Durham, NC. | Medical Specialties | Director/Board Member | |
Adlore, Inc.
![]() Adlore, Inc. Medical/Nursing ServicesHealth Services Adlore, Inc. is a medical device company that has developed a new device called Senlore™ to treat and monitor ulcerated wounds. The company is based in Kalamazoo, MI and was founded in 2019 by Eli L. Thomssen. Adlore™ aims to improve diabetic foot ulcer healing rates, which is a significant healthcare problem worldwide, as diabetes mellitus imposes a major economic burden on patients and the healthcare industry. | Medical/Nursing Services | Director/Board Member | |
Visus Therapeutics, Inc.
![]() Visus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Visus Therapeutics, Inc. is a clinical stage biopharmaceutical company that focuses on developing multi-targeted ophthalmic therapeutics for the front and back of the eye. The company is based in Seattle, WA and has subsidiaries in the United States. The company is developing novel, pupil-modulating therapeutics designed to correct the loss of near vision associated with presbyopia. In parallel, Visus is advancing its pipeline of early-stage ophthalmic drug candidates engineered to preserve and restore visual function associated with the leading causes of vision loss including cataract and presbyopia, ocular surface and corneal disease, glaucoma, and age-related macular degeneration. The company was founded by Benjamin Scot Bergo, Rhett M. Schiffman, and Benjamin Scot Bergo has been the CEO since incorporation. | Pharmaceuticals: Major | Director/Board Member | |
Frame Pharmaceuticals BV
![]() Frame Pharmaceuticals BV BiotechnologyHealth Technology Part of CureVac NV, Frame Pharmaceuticals BV is a Dutch company that offers cancer therapy services. The company is based in Amsterdam, Netherlands. The company was founded by Ronald Plasterk, Bob Löwenberg. Ronald Plasterk has been the CEO since incorporation. Frame Pharmaceuticals was acquired by CureVac NV on June 08, 2022 for $34.26 million. | Biotechnology | Founder | |
ONWARD MEDICAL N.V. | Miscellaneous Commercial Services | Director/Board Member | |
EQT Life Sciences Group BV
![]() EQT Life Sciences Group BV Investment ManagersFinance EQT Life Sciences Group BV (EQT Life Sciences) is a venture capital firm, a subsidiary of EQT AB founded in 2022 after the acquisition of LSP by EQT. The firm is headquartered in Amsterdam, the Netherlands. | Investment Managers | Private Equity Investor |
Statistiques
Internationale
Pays-Bas | 23 |
Etats-Unis | 17 |
Belgique | 4 |
Suisse | 3 |
Canada | 2 |
Sectorielle
Health Technology | 20 |
Consumer Services | 10 |
Consumer Non-Durables | 6 |
Finance | 5 |
Commercial Services | 3 |
Opérationnelle
Director/Board Member | 22 |
Corporate Officer/Principal | 12 |
Chief Executive Officer | 7 |
Undergraduate Degree | 6 |
Private Equity Investor | 6 |
Relations les plus connectées
- Bourse
- Insiders
- Henk Viëtor
- Connexions Sociétés